NewsBenzingaAbivax To Present Seven Scientific Abstracts On Obefazimod, Lead Drug Candidate For Treatment Of Active Ulcerative Colitis At UEG Week 2026 Meeting Abivax To Present Seven Scientific Abstracts On Obefazimod, Lead Drug Candidate For Treatment Of Active Ulcerative Colitis At UEG Week 2026 Meeting Benzinga 2026.09.30 20:16 (GMT+0) Open on Benzinga Other news Micron's fiscal Q4 revenue reaches $54.23 billion, up 379% year-over-year Here’s How Much You Would Have Made Owning Linde Stock In The Last 20 Years Massimo Group Enters Strategic Consulting Agreement With Acorn Management Partners On Sept 28, 2026; Agreement Term From Sept 28, 2026 To Sept 27, 2027; Company To Pay $15,000 Per Month Cash Compensation Under Agreement Valaris Says U.S. DOJ Closes Antitrust Investigation Into Valaris And Transocean Deal; Co And Transocean Expect Business Combination To Close In Q4 2026 WISeKey Intl Hldg H1 EPS $(0.22) Down From $(0.11) YoY, Sales $11.434M Up From $5.293M YoY Valor, Atreides, and Sequoia back AI startup Flow Engineering at $750M valuation
Massimo Group Enters Strategic Consulting Agreement With Acorn Management Partners On Sept 28, 2026; Agreement Term From Sept 28, 2026 To Sept 27, 2027; Company To Pay $15,000 Per Month Cash Compensation Under Agreement
Valaris Says U.S. DOJ Closes Antitrust Investigation Into Valaris And Transocean Deal; Co And Transocean Expect Business Combination To Close In Q4 2026
